References

1. de Vries, E.; Bray, F.I.; Coebergh, J.W.; Parkin, D.M. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: Rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int. J. Cancer 2003, 107, 119-126.

2. Australian Institute of Health and Welfare (AIHW); Australian Association of Cancer Registries (AICR). Cancer in Australia 1996: Incidence and mortality data for 1996 and selected data for 1997 and 1998; AIHW (Cancer Series): Canberra, Australia, 1999.

3. Norris, W. A case of fungoid disease. Edinb. Med. Surg. J. 1820, 16, 562-565.

4. Ford, D.; Bliss, J.M.; Swerdlow, A.J.; Armstrong, B.K.; Franceschi, S.; Green, A.; Holly, E.A.; Mack, T.; MacKie, R.M.; Osterlind, A.; Walter, S.D.; Peto, J.; Easton, D.F.; for The International Melanoma Analysis Group (IMAGE) Risk of cutaneous melanoma associated with a family history of the disease. Int. J. Cancer 1995, 62, 377 - 381.

5. Aitken, J.F.; Duffy, D.L.; Green, A.; Youl, P.; MacLennan, R.; Martin, N.G. Heterogeneity of melanoma risk in families of melanoma patients. Am. J. Epidemiol. 1994, 140, 961-973.

6. Aitken, J.F.; Bailey-Wilson, J.; Green, A.C.; MacLennan, R.; Martin, N.G. Segregation analysis of cutaneous melanoma in Queensland. Genet. Epidemiol. 1998, 15, 391-401.

7. Hayward, N.K. Genetics of melanoma predisposition. Oncogene 2003, 22, 3053-3062.

8. Palmer, J.S.; Duffy, D.L.; Box, N.F.; Aitken, J.F.; O'Gorman, L.E.; Green, A.C.; Hayward, N.K.; Martin, N.G.; Sturm, R.A. Melanocortin-1 receptor polymorphisms and risk of melanoma: Is the association explained solely by pigmentation phenotype? Am. J. Hum. Genet. 2000, 66, 176-186.

9. Box, N.F.; Duffy, D.L.; Chen, W.; Stark, M.; Martin, N.G.; Sturm, R.A.; Hayward, N.K. MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am. J. Hum. Genet. 2001, 69, 765-773.

10. van der Velden, P.A.; Sandkuijl, L.A.; Bergman, W.; Pavel, S.; van Mourik, L.; Frants, R.R.; Gruis, N.A. Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. Am. J. Hum. Genet. 2001, 69, 774-779.

11. Goldstein, A.M.; Fraser, M.C.; Struewing, J.P.; Hussussian, C.J.; Ranade, K.; Zametkin, D.P.; Fontaine, L.S.; Organic, S.M.; Dracopoli, N.C.; Clark, W.H., Jr.; Tucker, M.A. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. N. Engl. J. Med. 1995, 333, 970-974.

Kannengiesser, C.; Avril, M.F.; Spatz, A.; Laud, K.; Lenoir, G.M.; Bressac-de-Paillerets, B. CDKN2A as a uveal and cutaneous melanoma susceptibility gene. Genes Chromosomes Cancer 2003, 38, 265-268. Cannon-Albright, L.A.; Goldgar, D.E.; Meyer, L.J.; Lewis, C.M.; Anderson, D.E.; Fountain, J.W.; Hegi, M.E.; Wiseman, R.W.; Petty, E.M.; Bale, A.E.; Olopade, O.; Diaz, M.; Kwiatkowski, D.; Piepkorn, M.; Zone, J.; Skolnick, M. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science 1992, 258, 1148-1152.

14. Liu, L.; Dilworth, D.; Gao, L.; Monzon, J.; Summers, A.; Lassam, N.; Hogg, D. Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma. Nat. Genet. 1999, 21, 128-132.

15. Harland, M.; Mistry, S.; Bishop, D.T.; Bishop, J.A. A deep intronic mutation in CDKN2A is associated with disease in a subset of melanoma pedigrees. Hum. Mol. Genet. 2001, 10, 2679-2786.

16. Loo, J.C.; Liu, L.; Hao, A.; Gao, L.; Agatep, R.; Shennan,

Was this article helpful?

0 0
How To Prevent Skin Cancer

How To Prevent Skin Cancer

Complete Guide to Preventing Skin Cancer. We all know enough to fear the name, just as we do the words tumor and malignant. But apart from that, most of us know very little at all about cancer, especially skin cancer in itself. If I were to ask you to tell me about skin cancer right now, what would you say? Apart from the fact that its a cancer on the skin, that is.

Get My Free Ebook


Post a comment